Billion-dollar drug company nearly
squashes astounding research on natural cancer killer
Colon and breast cancer conquered with miracle tree from the Amazon found to be
10,000 times stronger than chemotherapy
Since our inception in 1996, Health Sciences
Institute has scoured the world to find cutting-edge treatments few people have access to
or have even heard about. And sometimes, what we uncover startles even the medical
mavericks on our board.
Two months ago, we learned about
an astounding cancer-fighting tree from the Amazon that has literally sent shock waves
through the HSI network
Today, the future of cancer treatment and
the chances of survival look more promising than ever. There's a healing tree that grows
deep within the Amazon rain forest in South America that could literally change how you,
your doctor, and possibly the rest of the world think about curing cancer. With extracts
from this powerful tree, it may now be possible to...
- conquer cancer safely and effectively with an
all-natural therapy that doesn't cause extreme nausea, weight loss, and hair loss
- protect your immune system and evade deadly
- feel strong and healthy throughout the course
- boost your energy and improve your outlook on
Through a series of confidential
communications involving a researcher from one of America's largest pharmaceutical
companies, this ancient tree's anticancerous properties have recently come to light.
Although not yet tested in human trials, the tree has been studied in more than 20
laboratory tests since the 1970s, where it's been shown to:
- effectively target and kill malignant cells
in 12 different types of cancer, including colon, breast, prostate, lung, and pancreatic
- be 10,000 times stronger in killing colon
cancer cells than Adriamycin, a commonly used chemotherapeutic drug
- selectively hunt down and kill cancer cells
without harming healthy cells, unlike chemotherapy
So why isn't every health publication
extolling the benefits of this treatment? Why hasn't it been made widely available
throughout the natural-medicine community? And, if it's only half as promising as it
appears to be, why isn't every oncologist at every major hospital insisting on using it on
all his patients? Especially when you consider that since the early 1990s, extensive
independent research--including research by one of today's leading drug companies and by
the National Cancer Institute--confirms that the tree's chemical extracts attack and
destroy cancer cells with lethal precision.
Graviola is 10,000 times stronger in killing colon cancer
than Adriamycin, a commonly used chemotherapeutic drug.
The answer to these difficult questions can
only be explained by recounting a disturbing story we recently uncovered. More than
anything else we've reported on this year, the story of this Amazon cancer treatment
reinforces the need for groups like HSI and illustrates how easily our options for medical
treatment are controlled by money and power.
News of this amazing tree was
nearly lost forever
A confidential source, whose account we've
been able to independently confirm, revealed that a billion-dollar drug company in the
United States tried for nearly seven years to synthesize two of the tree's most powerful
anticancerous chemicals. In the early 1990s, behind lock and key, this well-known drug
giant began searching for a cure for cancer--while preciously guarding their opportunity
to patent it and, therefore, profit from it.
Research focused on a legendary healing tree
called Graviola. Parts of the tree--including the bark, leaves, roots, fruit, and fruit
seeds--had been used for centuries by medicine men and native Indians in South America to
treat heart disease, asthma, liver problems, and arthritis. Going on little documented
scientific evidence, the company poured money and resources into testing Graviola's
anticancerous properties--and they were shocked by the results. Graviola was a
cancer-killing dynamo. But that's where the story of Graviola nearly ended.
The pharmaceutical company had a big
problem. They'd spent years trying to isolate and create man-made duplicates of two of the
tree's most powerful chemicals. But they'd hit a brick wall. They couldn't replicate the
original. And they couldn't sell the tree extract itself profitably--because federal law
mandates that natural substances can't be patented. That meant the company couldn't
protect its profits on the project it had poured millions of dollars and nearly seven
years of research into.
As the dream of big profits
evaporated, testing on Graviola came to a screeching halt
After seven frustrating years and without
the promise of lucrative sales, the company shelved the project and refused to publish its
findings in an independent journal. But one responsible researcher struggled with the
decision. While understanding the company's goal of profits, he couldn't accept the
decision to hide this unique cancer killer from the world. Following his conscience and
risking his career, he contacted Raintree Nutrition, a company dedicated to harvesting
plants from the Amazon.
As a result, Raintree went into high gear
and began to research related studies published on Graviola. They discovered that several
other teams in the United States (in addition to that of the drug company) had been
testing Graviola in vitro (in test tubes). The results supported the drug company's secret
findings; Graviola had been shown to kill cancer cells.
Encouraged by these early laboratory tests,
Raintree hired indigenous Indian tribes in Brazil to grow and harvest the tree.
Health Sciences Institute came across
Graviola and Raintree Nutrition a few months ago while researching Chanca Piedra, a
natural kidney-stone therapy from the Amazon, that was featured in our September 2000
issue. In the course of our working together, Raintree pointed us toward Graviola. And
needless to say, our panel of experts were intrigued by the possibility of this powerful
natural cure for cancer.
Graviola hunts down and destroys
prostate, lung, breast,
colon, and pancreatic cancers... leaving healthy cells alone
Since November, we've been looking closely
into the research to date on Graviola. It appears one of the first scientific references
to it in the United States was by the National Cancer Institute (NCI). In 1976, the NCI
included Graviola in a plant-screening program that showed its leaves and stems were
effective in attacking and destroying malignant cells. But the results were part of an
internal NCI report and were, for some reason, never released to the public.1
Since 1976, there have been several
promising cancer studies on Graviola. However, the tree's extracts have yet to be tested
on cancer patients. No double-blind clinical trials exist, and clinical trials are
typically the benchmark mainstream doctors and journals use to judge a treatment's value.
Nevertheless, Graviola has been shown to kill cancer cells in vitro in at least 20
laboratory tests that our research has uncovered.
The most recent study, conducted at Catholic
University of South Korea earlier this year, revealed that two chemicals extracted from
Graviola seeds showed "selective cytotoxicity comparable with Adriamycin" for
breast and colon cancer cells. The chemicals targeted and killed malignant breast and
colon cells in a test tube--comparable to the commonly used chemotherapy drug Adriamycin.2
Another study, published in the Journal
of Natural Products, showed that Graviola is not only comparable to Adriamycin--but
dramatically outperforms it in laboratory tests. Results showed that one chemical found in
Graviola selectively killed colon cancer cells at "10,000 times the potency of
Graviola selectively targets cancer cells leaving healthy cells
Chemotherapy indiscriminately seeks and destroys all actively
reproducing cells - even normal, healthy ones.
Other promising and ongoing research at
Purdue University is supported by a grant from the National Cancer Institute. Purdue
researchers recently found that leaves from the Graviola tree killed cancer cells
"among six human-cell lines" and were especially effective against prostate and
pancreatic cancer cells.4 In a separate study, Purdue researchers showed that
extracts from the Graviola leaves are extremely effective in isolating and killing lung
Perhaps the most significant result of the
study cited above from the Catholic University of South Korea, and of each of the others
we've found, is that Graviola was shown to selectively target the enemy--leaving all
healthy, normal cells untouched. By comparison, chemotherapy indiscriminately seeks and
destroys all actively reproducing cells--even normal hair and stomach cells. This is what
causes such often-devastating side effects as hair loss and severe nausea. In this
respect, Graviola looks to be a promising alternative or supplement to mainstream
Seven years of silence broken
We are continuing to work with Raintree and
others conducting ongoing research on Graviola. As more scientific and anecdotal evidence
comes to light, you'll be among the first to hear about it. However, after seven years of
silence and hidden research, we felt it irresponsible not to bring this to you now.
Grown and harvested by indigenous people in
Brazil, Graviola is available in limited supply in the United States and distributed only
through Raintree Nutrition. But now, you can be among a select few in the entire country
to benefit from Graviola. We encourage you, as always, to consult with your doctor before
beginning any new therapy, especially when treating cancer.
1. Unpublished data, National
Cancer Institute. Anon: Nat Cancer 1st Central Files--(1976)
from Napralert Files, University of Illinois, 1995
2. Bioorg Med Chem 8(1):285-90, 2000
3. J Nat Prod 59(2):100-108, 1996
4. Phytochemistry 49(2):565-71, 1998
5. J. Nat Prod 58(6):902-908, 1995
Graviola fights more than cancer...
While the research on Graviola
has focused on its cancer-fighting effect,
the plant has been used for centuries by medicine men in South America to
treat an astonishing number of ailments, including:
|high blood pressure
Despite the mounting collection of
laboratory tests and anecdotal reports about this cancer-fighting dynamo, Graviola may
always remain an underground therapy!
Graviola has yet to be
clinically tested on animals or humans. And because Graviola is a natural product, it can't be patented.
Without the promise of exclusive sales and high profitability, it will likely never again
draw the attention of a major drug company or research lab. So we may never see a
double-blind clinical study on the tree that's reported to help defeat cancer.
But there's no doubt about
it--the early laboratory tests and anecdotal reports about Graviola are very exciting. And
if you've been diagnosed with cancer, you and your doctor should look at all the available
treatment options. Graviola may just provide the help you've been looking for that could
make all the difference in beating cancer.
This article appeared in the monthly
publication of the Health Sciences Institute
© Copyrighted, 2001 by
Institute for Health Sciences L.L.C.,
819 N. Charles Street
Baltimore, MD 21201.
Published monthly for $74.00 per year.
Reprinted in part from: HEALTH SCIENCES INSTITUTE Members
Alert for January 2001 Vol. 5, No 7